scispace - formally typeset
C

Canwei Wang

Researcher at Wenzhou Medical College

Publications -  5
Citations -  173

Canwei Wang is an academic researcher from Wenzhou Medical College. The author has contributed to research in topics: Colorectal cancer & Cell growth. The author has an hindex of 3, co-authored 4 publications receiving 76 citations.

Papers
More filters
Journal ArticleDOI

miR-196b-5p–mediated downregulation of TSPAN12 and GATA6 promotes tumor progression in non-small cell lung cancer

TL;DR: The findings indicate that QKI-5 may exhibit novel anticancer mechanisms by regulating miRNA in NSCLC, and targeting the QKI5∼miR-196b-5p∼GATA6/TSPAN12 pathway may enable effectively treating some NSCLCs.
Journal ArticleDOI

Curcumin derivative WZ35 inhibits tumor cell growth via ROS-YAP-JNK signaling pathway in breast cancer

TL;DR: Treatment of breast cancer cells with WZ35 exerts stronger anti-tumor activities than curcumin both in vitro and in vivo, and novel anti-cancer mechanisms of WZ34 and ROS-YAP-JNK pathway might be a potential therapeutic target for the treatment of breastcancer patients.
Journal ArticleDOI

Gracillin shows potent efficacy against colorectal cancer through inhibiting the STAT3 pathway.

TL;DR: Gracillin shows potent efficacy against CRC by inhibiting the STAT3 pathway and should be further explored as a unique STAT3 inhibitor for the treatment of CRC.
Journal ArticleDOI

Dihydroartemisinin enhances the anti-tumor activity of oxaliplatin in colorectal cancer cells by altering PRDX2-reactive oxygen species-mediated multiple signaling pathways.

TL;DR: In this article , an improved therapeutic strategy for colorectal cancer patients by combining DHA and oxaliplatin treatments was demonstrated. But, the direct target of DHA was not clarified and underlying molecular mechanisms in oxalplatin-mediated anti-tumor activities against CRC are unclear.